Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (5 quarters reported)
$149M in Q4 2023 → — now. Hover for any quarter.
As reported for the quarter ended December 31, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| NS No Securities | NaN% | Unchanged | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 4 quarters.
quarter ended December 31, 2024 · filed February 14, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed November 14, 2024
No position changes this quarter.
quarter ended June 30, 2024 · filed August 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Legend Biotech Corp | Exited | −652,732 | −$36.6M | — |
| Danaher Corporation | Exited | −108,700 | −$27.1M | — |
| Bridgebio Pharma Inc | Exited | −612,060 | −$18.9M | — |
| SG Stevanato Group S P A | Exited | −550,000 | −$17.7M | — |
| Apellis Pharmaceuticals Inc | Exited | −287,277 | −$16.9M | — |
| Thermo Fisher Scientific Inc | Exited | −18,400 | −$10.7M | — |
| Arrivent Biopharma Inc | Exited | −555,555 | −$9.92M | — |
| Structure Therapeutics Inc | Exited | −205,166 | −$8.79M | — |
| KP Kiniksa Pharmaceuticals Ltd | Exited | −400,441 | −$7.9M | — |
| Janux Therapeutics Inc | Exited | −193,300 | −$7.28M | — |
Showing the 10 largest of 31 changes.
quarter ended March 31, 2024 · filed May 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SG Stevanato Group S P A | New | +550,000 | +$17.7M | 7.6% |
| Argenx Se | Exited | −29,500 | −$11.2M | — |
| Biomarin Pharmaceutical Inc | Exited | −114,042 | −$11M | — |
| Thermo Fisher Scientific Inc | New | +18,400 | +$10.7M | 4.6% |
| Arrivent Biopharma Inc | New | +555,555 | +$9.92M | 4.2% |
| Structure Therapeutics Inc | New | +205,166 | +$8.79M | 3.8% |
| Apellis Pharmaceuticals Inc | Added | +135,077 | +$7.94M | 7.2% |
| Exact Sciences Corp | Exited | −99,130 | −$7.33M | — |
| Janux Therapeutics Inc | New | +193,300 | +$7.28M | 3.1% |
| EL Eli Lilly & Co | New | +9,200 | +$7.16M | 3.1% |
Showing the 10 largest of 32 changes.
Loading...
